Hinge Health, Inc.
HNGE NYSE· Services-Computer Processing & Data Preparation
Last close · Oct 23, 2026
$111.52
KIRA · Stoqly’s AI analyst, in plain words
- Hinge Health, Inc. had $588M of revenue in fiscal 2025, up 50.6% on the year before.
- Its operating margin was −92.9%, down 84.8 pts: of every 100 in sales, about −93 is left after running the business.
- Hinge Health, Inc. lost $528M in fiscal 2025.
- Free cash flow was $171M in fiscal 2025, 29.0% of revenue.
- Hinge Health, Inc. returned $65.0M to shareholders in fiscal 2025, 38% of free cash flow. The diluted share count rose 302.5%.
Market cap
$9.3B
P/E
22.5x
Revenue
$588M
Net income
−$528M
Free cash flow
$171M
Operating margin
−92.9%
Hinge Health, Inc. in 30 seconds · fiscal 2025
Are sales growing?
+50.6%
Yes. Sales grew 50.6% last year.
Does it make a profit?
−89.9%
No. It lost money last year.
Does profit turn into cash?
29.0%
Yes. 29.0% of sales ends up as free cash.
How healthy are the accounts?
4 / 8
Mixed. It passes 4 of 8 health tests.
How is the share priced?
22.5x
One share costs 22.5 times its yearly profit per share.
What Hinge Health, Inc. does
No business description yet.
- Fiscal year ends
- December 31, 2025
- Latest annual report
- 10-K · Mar 3, 2026
- Legal name
- Hinge Health, Inc.
- CIK
- 0001673743
Hinge Health, Inc. · HNGE
Results and finances
The last 3 fiscal years. Amounts in USD.
| Fiscal year | FY23 | FY24 | FY25 |
|---|---|---|---|
| Sales and profit | |||
| Revenue | $293M | $390M | $588M |
| Revenue growth | — | 33.4% | 50.6% |
| Gross margin | 66.3% | 76.8% | 79.6% |
| Operating margin | −44.6% | −8.2% | −92.9% |
| Net income | −$108M | −$11.9M | −$528M |
| Net margin | −36.9% | −3.1% | −89.9% |
| Diluted EPS | −$8.31 | −$0.88 | −$7.77 |
| Cash | |||
| Cash from operations | −$63.9M | $49.0M | $171M |
| Capital expenditure | $2.0M | $1.0M | $0.7M |
| Free cash flow | −$65.9M | $48.0M | $171M |
| FCF margin | −22.5% | 12.3% | 29.0% |
| Share buybacks | $0.0M | $0.0M | $65.0M |
| Share count change | — | 4.2% | 302.5% |
| Debt and strength | |||
| Cash and short-term investments | $235M | $467M | $364M |
| Shareholders' equity | −$424M | −$435M | $179M |
| Current ratio | — | 2.3x | 1.5x |
| Returns and quality | |||
| Return on tangible equity | — | — | −378.5% |
| Piotroski F-score | — | — | 4 |
| Altman Z'' | — | −1.4 | −7.5 |
Insiders bought, 12 months
$0.0M
0 insiders
Insiders sold, 12 months
$543M
10 insiders
Of sales under plans
80%
$435M
How to read these numbers
- Revenue:
- Total sales reported in the income statement.
- Operating margin:
- Operating income as a share of revenue.
- Net income:
- Profit after all expenses, interest and tax.
- Free cash flow:
- Cash from operations minus capital spending.
- Net debt / EBITDA:
- Years of EBITDA needed to pay off net debt. Below zero means more cash than debt.
- Return on capital:
- After-tax operating income as a share of the money invested in the business: debt plus equity, minus cash.
Hinge Health, Inc. · HNGE
Charts and comparison
Ten years at a glance, and how it stacks up against similar companies.
Revenue
Net income
Margins, % of revenue
Cash vs debt (incl. leases)
Free cash flow
Dividends and buybacks
KIRA
At $111.52 a share, the company is worth $9.3B: 22.5 times its earnings of the last four quarters.
Source: SEC EDGAR XBRL filings (CIK 0001673743). Data updated October 24, 2026. For information only — not investment advice. Check the original filings before relying on any figure.